Traitements8programmes
Essais5liés
Publications5liées
SourceDBlocale

Traitements

8
MoléculeIndication / populationPhaseObjectifPaysRésultat
CreatineDescription non affichée : incohérence de maladie détectée. Consultez l’essai clinique officiel associé. Parkinson, Sclérose latérale amyotrophique Phase 3 À vérifier United States, Canada À vérifier
Dyadic Life Review Intervention for Older Patients With Advanced Cancer and Alzheimer's Disease and Related Dementias and Their CaregiversThe purpose of this study is to evaluate the efficacy of Dyadic Life Review (DLR) therapy for reducing caregiver distress, measured by caregiver burden to capture the multifaceted experience of distress, among older adults with advanced cancer and cognitive impairment and their caregivers. Alzheimer Non applicable À vérifier United States À vérifier
REACH-DM KIDS — Remote Assessments and Genetic Determinants of Congenital and Childhood Myotonic DystrophyMyotonic dystrophy type 1 (DM1) can affect people in many different ways, even in the same family. The symptoms that children experience can be different and more severe than adults. Prior studies in children have been limited because only a small number of children could participate. In this study, we hope to learn more about these differences and what causes them. This is an observational study conducted in participants' homes and does not require travel. Instead, we will use video calls to talk with children and their parents/guardians about DM1 symptoms and how it affects the child's muscles, heart, and brain. We'll send families an iPad and the other tools they need for the study. During the video call, kids will do some simple activities to see how their body moves and functions. Parents/guardians might need to help their child with some of these activities. After the video visit, we'll get a small blood sample from the child. This can be done at a local lab or even at home. We'll then look at the child's genes in the blood sample to understand how they might be linked to their symptoms. Parents/guardians can chose to have their child's genetic test result returned to them. Myopathies À vérifier Traitement symptomatique United States À vérifier
The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular DystrophyThe aim of the BABY DUCHENNE study is to evaluate the natural history and characterize the early clinical outcomes in very young children (0-3 years) with Duchenne muscular dystrophy (DMD) identified by newborn screening programs. Myopathies À vérifier À vérifier United States À vérifier
REACH-DM KIDS — Remote Assessments and Genetic Determinants of Congenital and Childhood Myotonic DystrophyMyotonic dystrophy type 1 (DM1) can affect people in many different ways, even in the same family. The symptoms that children experience can be different and more severe than adults. Prior studies in children have been limited because only a small number of children could participate. In this study, we hope to learn more about these differences and what causes them. This is an observational study conducted in participants' homes and does not require travel. Instead, we will use video calls to talk with children and their parents/guardians about DM1 symptoms and how it affects the child's muscles, heart, and brain. We'll send families an iPad and the other tools they need for the study. During the video call, kids will do some simple activities to see how their body moves and functions. Parents/guardians might need to help their child with some of these activities. After the video visit, we'll get a small blood sample from the child. This can be done at a local lab or even at home. We'll then look at the child's genes in the blood sample to understand how they might be linked to their symptoms. Parents/guardians can chose to have their child's genetic test result returned to them. Myopathies À vérifier Traitement symptomatique United States À vérifier
CreatineThe objective of this study is to compare two combinations of drugs, minocycline and creatine or celecoxib and creatine, in a phase II trial designed to determine which combination is more effective for ALS. Parkinson Phase 3 À vérifier United States, Canada À vérifier
The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular DystrophyThe aim of the BABY DUCHENNE study is to evaluate the natural history and characterize the early clinical outcomes in very young children (0-3 years) with Duchenne muscular dystrophy (DMD) identified by newborn screening programs. Myopathies À vérifier À vérifier United States À vérifier
Dyadic Life Review Intervention for Older Patients With Advanced Cancer and Alzheimer's Disease and Related Dementias and Their CaregiversThe purpose of this study is to evaluate the efficacy of Dyadic Life Review (DLR) therapy for reducing caregiver distress, measured by caregiver burden to capture the multifaceted experience of distress, among older adults with advanced cancer and cognitive impairment and their caregivers. Alzheimer Non applicable À vérifier United States À vérifier

Essais cliniques

5
MoléculeIndication / populationPhaseNCTTitreStatut
Dyadic Life Review Intervention for Older Patients With Advanced Cancer and Alzheimer's Disease and Related Dementias and Their Caregivers Alzheimer Non applicable NCT07796347 Dyadic Life Review Intervention for Older Patients With Advanced Cancer and Alzheimer's Disease and Related Dementias and Their Caregivers NOT_YET_RECRUITING
The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy Myopathies À vérifier NCT07092540 The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy RECRUITING
Creatine Parkinson Phase 3 NCT00449865 NET-PD LS-1 Creatine in Parkinson's Disease TERMINATED
REACH-DM KIDS — Remote Assessments and Genetic Determinants of Congenital and Childhood Myotonic Dystrophy Myopathies À vérifier NCT07630389 REACH-DM KIDS — Remote Assessments and Genetic Determinants of Congenital and Childhood Myotonic Dystrophy RECRUITING
Minocycline Parkinson Phase 2 NCT00063193 National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial COMPLETED

Publications

5
MoléculeIndication / populationTitreJournalDate
Creatine Real-world creatine supplementation: a large-scale cross-sectional study of use, knowledge, and experiences. Journal of the International Society of Sports Nutrition
Creatine Delaying task failure in high-intensity exercise: a Pi-afferent-effort framework for targeted sports nutrition. Journal of the International Society of Sports Nutrition
Creatine Shuxin oral liquid attenuates isoproterenol-induced myocardial fibrosis in rats: Association with downregulation of the TGF-β/Smad signaling pathway. Journal of ethnopharmacology
Creatine Metabolomic Insights on Obesity and Diabetes from Feeding Diets Varying in Carbohydrate-Fat Ratios in Zucker Diabetic Fatty (ZDF) and Lean Zucker (Z) Rats. International journal of molecular sciences
Creatine Delayed Serum Creatine Kinase Elevation After Snakebite: Serial Changes and Clinical Correlates of Myotoxicity in a Korean Tertiary-Care Cohort. Journal of clinical medicine